Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sumeet Panjabi

Letter: Quest for the Best in Relapsed/Refractory Multiple Myeloma: A Mis-Placed ENDEAVOR

Clinical Therapeutics

English

Cost-Effectiveness of Adding Carfilzomib to Lenalidomide and Dexamethasone in Relapsed Multiple Myeloma From a US Perspective

Journal of Medical Economics

English

Related publications

Carfilzomib for Relapsed or Refractory Multiple Myeloma

The Lancet Oncology

English

Bendamustine in Patients With Relapsed or Refractory Multiple Myeloma

European Journal of Medical Research

English

Bendamustine, Pomalidomide, and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma

Blood Cancer Journal

English

Pcn311 - European Market Access Challenges for Relapsed Refractory Multiple Myeloma Triplet Therapies

Value in Health

Occupational Health

English

Daratumumab vs. Pomalidomide for the Treatment of Relapsed/Refractory Multiple Myeloma: A Cost‐effectiveness Analysis

American Journal of Hematology

English

Retreatment With Bendamustine-Bortezomib-Dexamethasone in a Patient With Relapsed/Refractory Multiple Myeloma

Case Reports in Hematology

English

Optimizing the Use of Lenalidomide in Relapsed or Refractory Multiple Myeloma: Consensus Statement

Cancer Research

English

Phase 1b Trial of Pembrolizumab Monotherapy for Relapsed/Refractory Multiple Myeloma: KEYNOTE ‐013

British Journal of Haematology

English

Atacicept in Relapsed/Refractory Multiple Myeloma or Active Waldenström's Macroglobulinemia: A Phase I Study

British Journal of Cancer

Cancer Research

English